For this analysis, we used two RBPs; (a) DGCR8 (DiGeorge Syndrome Critical Region 8), which is involved in microRNA processing and is implicated in the pathogenesis of cancer38,39 and (b) IGF2BP1 (insulin like growth factor 2 mRNA binding protein 1) which is a critical post-transcriptional regulator of various mRNA involved in cancer progression40. This evidence concerns the gene DGCR8 and cancer.